This document provides information about dementia to help general practitioners increase their understanding and ability to support patients and families affected by dementia. It defines different types of dementia, describes common symptoms, discusses the impact on brain regions, and provides case studies and models to illustrate experiences. It also offers guidance on communication strategies, visual issues patients may experience, and resources to help practices become more dementia-friendly.
How can you tell if forgetfulness is the result of normal age-related memory changes or if it's the result of something more? This is a very important distinction to make, and the earlier the better.
This is a presentation I did last spring in which I discuss how the OTPF applies to Alzheimer's Dementia. I collected data from scholarly as well as non-scholarly resources. I hope you find this to be helpful.
This presentation by Dr Anita Rose, Consultant Neuropsychologist, looks at cognition and MS. It explores assessment, managing cognitive deficits and factors assessing cognition including pain, emotions and fatigue.
It was presented at the MS Trust Annual Conference in November 2013.
How can you tell if forgetfulness is the result of normal age-related memory changes or if it's the result of something more? This is a very important distinction to make, and the earlier the better.
This is a presentation I did last spring in which I discuss how the OTPF applies to Alzheimer's Dementia. I collected data from scholarly as well as non-scholarly resources. I hope you find this to be helpful.
This presentation by Dr Anita Rose, Consultant Neuropsychologist, looks at cognition and MS. It explores assessment, managing cognitive deficits and factors assessing cognition including pain, emotions and fatigue.
It was presented at the MS Trust Annual Conference in November 2013.
Dementia Home Care in India: Overview and Challenges ARDSICON 2015Swapna Kishore
Dementia Home Care in India: Overview and Challenges--- A presentation made at ARDSICON 2015, the 19th National Conference of ARDSI (Alzheimer's and Related Disorders Society of India), held at Mumbai, India.
If you are concerned about dementia home care, also see the pages at: http://dementiacarenotes.in/caregivers
Differentiating depression and dementia gendron and heckwef
Live webinar recorded June 26, 2012 featuring Tracey L. Gendron and Dr. Andrew L. Heck - discussion moderated by Dr. E. Ayn Welleford. View details at www.alzpossible.org
The ppt covers all aspects concerning organic brain disorder - Dementia and Delirium. It includes Alzheimer's, Parkinson's along with clinical features (according to ICD 10); cognitive, physical, neurobiological changes; treatment and assessment scales. Diagrams and charts are included wherever necessary for ease of understanding.
Aging is associated with cognitive decline, and older subjects can have demonstrable cognitive impairment without crossing the threshold for dementia.
This condition has been termed “mild cognitive impairment” (MCI), and these patients have an increased risk of developing dementia, especially Alzheimer disease (AD).
Studies conducted in referral clinics have shown that patients with MCI progress to AD at a rate of 10% to 15% per year, and 80% of these patients have converted to AD after approximately 6 years of follow-up.
The identification and classification of MCI can be a major challenge.
Dementia is an umbrella term used to cover several conditions that all result in the decline of a patient's cognitive abilities. Learn about the different types of Dementia.
Mental health issues such as depression and anxiety are NOT a normal part of aging and are hard to discuss, diagnose and treat. The good news is that there are innovative programs, tools and resources that can help.
Dementia introduction slides by swapnakishore released cc-by-nc-saSwapna Kishore
Dementia awareness presentation intended for general public/ patients/ potential and existing caregivers/ volunteers interested in spreading dementia awareness.
Visit my site for more information: http://dementiacarenotes.in
A complete presentation about all-aspects of the Alzheimer's disease, including Patho Physiology, Treatment, Nursing Management, Prevention, Disease Overview, Clinical Manifestation, etc.
Dementia Home Care in India: Overview and Challenges ARDSICON 2015Swapna Kishore
Dementia Home Care in India: Overview and Challenges--- A presentation made at ARDSICON 2015, the 19th National Conference of ARDSI (Alzheimer's and Related Disorders Society of India), held at Mumbai, India.
If you are concerned about dementia home care, also see the pages at: http://dementiacarenotes.in/caregivers
Differentiating depression and dementia gendron and heckwef
Live webinar recorded June 26, 2012 featuring Tracey L. Gendron and Dr. Andrew L. Heck - discussion moderated by Dr. E. Ayn Welleford. View details at www.alzpossible.org
The ppt covers all aspects concerning organic brain disorder - Dementia and Delirium. It includes Alzheimer's, Parkinson's along with clinical features (according to ICD 10); cognitive, physical, neurobiological changes; treatment and assessment scales. Diagrams and charts are included wherever necessary for ease of understanding.
Aging is associated with cognitive decline, and older subjects can have demonstrable cognitive impairment without crossing the threshold for dementia.
This condition has been termed “mild cognitive impairment” (MCI), and these patients have an increased risk of developing dementia, especially Alzheimer disease (AD).
Studies conducted in referral clinics have shown that patients with MCI progress to AD at a rate of 10% to 15% per year, and 80% of these patients have converted to AD after approximately 6 years of follow-up.
The identification and classification of MCI can be a major challenge.
Dementia is an umbrella term used to cover several conditions that all result in the decline of a patient's cognitive abilities. Learn about the different types of Dementia.
Mental health issues such as depression and anxiety are NOT a normal part of aging and are hard to discuss, diagnose and treat. The good news is that there are innovative programs, tools and resources that can help.
Dementia introduction slides by swapnakishore released cc-by-nc-saSwapna Kishore
Dementia awareness presentation intended for general public/ patients/ potential and existing caregivers/ volunteers interested in spreading dementia awareness.
Visit my site for more information: http://dementiacarenotes.in
A complete presentation about all-aspects of the Alzheimer's disease, including Patho Physiology, Treatment, Nursing Management, Prevention, Disease Overview, Clinical Manifestation, etc.
Most often, AD is diagnosed in people over the age of 65, but early-onset Alzheimer’s can occur much earlier. There are four stages of Alzheimer’s Disease.
what is dementia and why it is considered only for old age and how it goes to misdiagnose buy the health care professionals and what is infact. in nepal this issues is given low priority in both hospital and public
10 warning signs of dementia, as opposed to 10 signs of "normal" aging of the brain. Also, what you can do now to prepare yourself, and helpful tips when communicating with a loved one with signs of a neurocognitive disorder.
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for DimentiaShewta shetty
Homeopathic Doctor Anita Salunke practices in Chembur, Mumbai, India in her homeopathic clinic Mindheal. Find more information about homeopathic treatment at Mindheal. Welcome to safe, sure and effective homeopathic treatment Dimentia
Dementia is a general decline in the cognitive function of the brain caused by various disorders. It is not a normal part of ageing. Dementia symptoms (and Alzheimer's symptoms) can include difficulty with concentration, spatial and temporal confusion, memory loss, mood changes, struggling with conversations, and withdrawal from social interactions.
Dementia is a general decline in the cognitive function of the brain caused by various disorders. It is not a normal part of ageing. Dementia symptoms (and Alzheimer's symptoms) can include difficulty with concentration, spatial and temporal confusion, memory loss, mood changes, struggling with conversations, and withdrawal from social interactions.
Dementia is an acquired global impairment of intellect, memory and personality but without impairment of consciousness“
Or
According to WHO
Dementia is a syndrome in which there is deterioration in cognitive function beyond what might be expected from the usual consequences of biological ageing.
This presentation is made after a lot of effort, as I had to face this awesome situation, in the life of my mother Lilly Michael, who finally died on 16.11.2005, at the age of 81.
Similar to Dementia awareness for surgeries - Wiltshire (20)
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing opioid prescribing, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, SBAR Patient Engagement Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing medication related falls risk in patients with severe frailty, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Assessing the outcomes of structured medication reviews, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy SMR reviews in outpatient bone health clinics, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Genome UK – State of the nation by Professor Dame Sue Hill, Chief Scientific Officer for England and NHS Genomics Programme Senior Responsible Officer.
Pharmacogenomics into practice - stroke services and a systems approach by Dr Richard Marigold, Consultant Stroke Physician and NIHR Hyperacute Stroke Research Centre Lead, University Hospital Southampton NHS Foundation Trust
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary,
Review of patients on high dose opioids at Living Well PCN, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Re-establishing autonomy in elderly frail patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving Medication Reviews using the NO TEARS Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Improving care in County Durham under the STOMP agenda - A 5 year review.pdfHealth Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving care in County Durham under the STOMP agenda - A 5 year review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Impact of an EMIS search to prioritise care home residents for a pharmacist l...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Impact of an EMIS search to prioritise care home residents for a pharmacist led medication review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Identifying Orthostatic Hypotension caused by Medication, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
2. Contents:
Why are we here?
Understanding Dementia
The Brain
Symptoms – four main
dementias
Case Studies
Models
Visual problems
Communication
Further Resources
Questions
3. This is designed as an interactive session to use in
general practice to increase the understanding of a
condition that affects many of your patients and
has a significant impact on their family.
5. Figures
• 1 in 14 people over 65 have dementia.
• 1 in 6 people aged 80 and over have dementia.
• 850,000 people live with dementia in the UK today.
• 15,000 (approx) people living with dementia in Wilts
6. Facts
• Two thirds of people with dementia are women
• At end of life, one third of people will have dementia
• Dementia is most common in older people but
younger people (under 65) can get it too.
40-64 years: 1 in 1,400
65-69 years: 1 in 100
70-79 years: 1 in 25
80+ years: 1 in 6
9. The occipital lobe
dementia in this part of
the brain leads to PCA or
Posterior Cortical Atrophy.
This affects the visual
processing – recognition
of colours/shapes, faces
and ability to read.
1. Frontal Lobe controller:
damage to the frontal
lobes can lead to the
individuals no longer
being aware of what
actions seen by others are
inappropriate
2. The non-dominant
parietal lobe
Our 3D ‘centre’. Makes
objects being viewed look
3D. It also helps our
understanding of space –
to locate objects, e.g.
when picking something
up.
3. The dominant parietal
lobe
Our body sense: knowing
our left from our right,
sensing where a limb is,
putting things together
into a structure such as
reading and calculation
4. The temporal lobe:
damage to this area of the
brain causes the individual to
have problems with short
term memory and over time
the term memories may also
fade as the damage increases
further into the deeper
regions of the brain
5. The occipital lobe
Dementia in this part of the
brain leads to PCA or
Posterior Cortical Atrophy.
This affects the visual
processing, so recognition of
colours/shapes, faces and
ability to read.
11. Alzheimer’s disease
• Most common cause of dementia
• A physical disease affecting the brain
• Protein ‘plaques’ and ‘tangles’ develop in the
structure of the brain, leading to the death of
brain cells ) often in the temporal lobe).
• It also leads to a shortage of some important
chemicals in the brain.
• Over time more parts of the brain are damaged
and the symptoms become more severe.
12. Symptoms of Alzheimer’s disease
People with Alzheimer’s disease may
• Become confused and frequently forget names,
appointments and recent events.
• Experience mood swings, feel sad or angry, or scared
and frustrated.
• Become more withdrawn, due to either a loss of
confidence or to communication problems.
• Have difficulty carrying out everyday activities –
checking their change at the shops or how to work
the TV remote.
13. Vascular Dementia
• The second most common
form of dementia.
• Caused by problems in the
supply of blood to the
brain due to damage to
the vascular system (the
network of blood vessels).
• Damage to the vascular
system could be caused by
strokes, high blood
pressure, heart problems,
high cholesterol and
diabetes.
14. Symptoms of Vascular Dementia
People with vascular dementia may experience
• Problems concentrating and communicating.
• Depression accompanying the dementia.
• Physical weakness or paralysis.
• Memory problems.
• A ‘stepped’ progression with symptoms remaining at
a constant level and then suddenly deteriorating.
• Seizures.
• Periods of acute confusion.
15. Dementia with Lewy bodies
• Around ten per cent of
cases of dementia.
• Lewy bodies are tiny,
spherical protein deposits
found in nerve cells.
• They disrupt the brain’s
normal functioning,
interrupting the action of
important chemical
messengers.
16. Symptoms of Dementia with
Lewy bodies
• May have problems with:
attention and alertness,
spatial disorientation,
planning ahead
co-ordinating mental activities.
• Memory is often affected less
than in Alzheimers
• May develop symptoms of
Parkinson’s disease:
Slowness, shuffling gait
limb tremor, muscle stiffness,
loss of facial expression
change in voice strength
• May experience detailed
and convincing visual
hallucinations.
• May have fluctuating
abilities daily or even
hourly.
• May fall asleep easily by
day yet have restless
disturbed nights.
• May faint, fall or have
‘funny turns’.
17. Symptoms of Fronto-Temporal
Dementia
• Poor judgement
• Loss of empathy
• Socially inappropriate
behaviour
• Lack of inhibition
• Repetitive compulsive
behaviour
• Inability to concentrate or
plan
• Frequent, abrupt mood
changes
• Speech difficulties
• Problems with balance or
movement
• Memory loss
20. “Aggressive” Behaviour
• May be verbally abusive
• Physically, hitting, kicking,
pinching and lashing out
This may be caused by:
• Feeling frightened or humiliated
• Feeling frustrated about their lack
of understanding or
communication problems
• Dementia may have eroded their
judgement and control
• Loss of inhibitions and decreased
awareness of appropriate
behaviour
23. Feedback
from focus
groups
Clarity
about roles
A priority
approach
for carers
Consistency
in every
practice
Accessible
information
Training for
staff
We didn’t know
where she was
from, or what
she did
He got lost - this
happened a few
weeks after the
doctor said he
was fine
I find it difficult to
ask people for help.
We just carry on -
they don’t offer, but
then I don’t demand
The nurse turned
to me and said, “Is
she compos
mentis?” I was
angry, and upset
The GPs can be quite
patronising - they talk to
him as though he doesn’t
understand anything
Some staff can be
aggressive towards him
- they seem to think
they have nothing to
learn
It’s just places to go and
people to be with we need
The GP tests him every
year, and that’s really
helpful.” “The GP said that
they wouldn’t have time
We can’t always see the
same GP – it’s
frustrating when you
have to go over it all
again and again
The toilets do need to be
clearly marked –
sometimes you need
them in a hurry
Living with it or
suffering it?
Well, you’ve got
to do both,
haven’t you?”
(Carer)
There was this flurry of
activity, and lots of
information just after the
diagnosis, but then
nothing - it felt as if we
were just left to get on
with it
24. Small Changes…… Big Differences…..
1.Make sure all health-care staff know whether a
patient has dementia before they are seen
2.Remember! People living with dementia may need a
longer appointment
3.Don’t let people with dementia fall out of the system
if they don’t keep appointments (NB If someone
without a dementia diagnosis repeatedly forgets to
attend appointments, it may be a sign that they
should be screened)
4.If possible, send appointment reminders to both
patient and carer
25. Small Changes…… Big Differences…..
5. Where appropriate, include family carers in decision
making
6. Ensure family members have copies of relevant
documents – letters, monitoring equipment,
appointments, changes to medication etc
7. Continuity of care is very important to the person
with dementia – it is better to be seen by the same
health-care professional on each visit
26. Visual Difficulties
• Hallucinations: an experience of something that is
not really there. They can occur for all the senses,
though visual hallucinations are the most common.
• Visual Misperception: when the individual mistakes
something for something else.
27. This mirror at the bathroom entrance has caused
residents to leave, thinking it was occupied although
they were seeing their own reflections.
32. Communication
• Before you speak
• When you speak
• What to say
• Listening
• Body Language and Physical Contact
33. Perceptions of what life is like for
people with dementia…
• 58% thought quality of life was fairly bad or very
bad
• 52% thought that care provided was fairly bad or
very bad
• 61% thought inclusion in communities was fairly
bad or very bad
YouGov survey 2011
34. People with dementia feel that
their community could help by:
• Better understanding of dementia and less social
stigma
• More public awareness of the condition
• More local activities and opportunities to socialise
• More tolerance and patience from others
• More community spirit
Source: Alzheimer’s Society Dementia 2012 Report
35. NHS Commitment to raising
awareness
• Awareness – understanding symptoms, recognising
signs, challenging behaviour.
• Knowledge of the condition – types of dementia,
differences between dementia, delirium, depression
etc.
• Communications, listening skills and supporting
people with dementia.
• Person centered care – sign posting to advice and
guidance, medication, ethics, impact on families.
36. Risk factors for developing
dementia
• Age
• Lack of physical exercise
• Obesity
• Mental activities in mid life
• Diabetic
• Current Smoking
• Excess alcohol
• Genetics
• Learning disabilities
38. Diagnosis – the earlier the better
Only 1/3 of people with dementia have a proper
diagnosis.
Early diagnosis means that:
• There is more time to plan ahead and support self
management
• The carer is able to cope for longer
• The need for placement of the patient away from
their home is delayed
39. Support for Carers and Family
• Registering as a carer with GP
• Carers assessment
• Memory advisors and support teams
• Carers’ Leads
• Alzheimer’s Society
• Adult /social care services
40. What can we do?
• Become “dementia friends”
• (see ’Video about dementia friends’ if access to the
internet is available)
• Support national campaigns
• Become a ‘Dementia Friendly Practice’
41. Our role as a dementia friendly
practice
• Maximise health and well-being and help people to
remain independent
• Improve patient and carer experience
• Improve teamwork
• Improve clinical consultations – better prescribing &
improved referrals
• Improved care planning for the future
• Improved quality of life for our patients
• Know & be able to sign post patients to available
services
42. Where can you find more
information?
• www.alzheimers.org.uk
• www.dementia.org.uk.
• www.dementiafriends.org.uk
• www.scie.org.uk (e-learning)